Searchable abstracts of presentations at key conferences in endocrinology

ea0035p569 | Endocrine tumours and neoplasia | ECE2014

Patient with dissemination of neuroendocrine neoplasm of unknown origin and carcinoid syndrome: diagnostic and therapeutic difficulties

Stefanka Agnieszka , Sowa-Staszczak Anna , Hubalewska-Dydejczyk Alicja , Mikolajczak Renata

Introduction: Serotonin producing neuroendocrine tumors are usually well differentiated, small lesions localised in the small intestine. Visualisation of the primary tumor might be difficult due to its small size.Case report: A 52 years old man presented with diarrhoea and flushes. Ultrasound examination and computed tomography of the abdomen revealed numerous lesions in the liver. Gastroscopy, colonoscopy and magnetic resonance imaging did not reveal th...

ea0035p572 | Endocrine tumours and neoplasia | ECE2014

Peptide receptor radionuclide therapy as neoadjuvant treatment

Stefanska Agnieszka , Sowa-Staszczak Anna , Hubalewska-Dydejczyk Alicja , Mikolajczak Renata

Introduction: Peptide receptor radionuclide therapy is indicated in case of patients with disseminated neuroendocrine tumors and is usually considered as palliative treatment.Case reports: 55 years old man diagnosed with tumor of the pancreatic head. On laparotomy performed in June 2012 tumor was stated unresectable. Histopathological examination revealed the mixed adeno-neuroendocrine cancer (MANEC). Patient was qualified to chemotherapy with gemcitabin...

ea0035p793 | Paediatric endocrinology | ECE2014

Effectiveness of GH therapy in children with normal results of GH stimulation tests and with partial GH deficiency is similar and depends on the severity of IGF1I deficiency

Smyczynska Joanna , Stawerska Renata , Lewinski Andrzej , Hilczer Maciej

Introduction: GH therapy in children with normal GH peak in stimulation tests (GHST) is still a matter of discussion. Recently, GH deficiency (GHD) has been defined as secondary IGF1 deficiency (IGFD), however GHST still remain the main procedure in diagnosing GHD.The aim of present study was to compare GH therapy effectiveness in the patients with normal results of GHST (normGH) and with isolated partial GHD (pGHD), with respect to IGF-I secretion befor...

ea0070aep406 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Connection of glucose control with the 25-OH vitamin D status in type 1 diabetic young patients

Navasardyan Lusine , Ghubatyan Anna , Markosyan Renata , Aghajanova Yelena

Background and aims: A growing number of studies show the impact of vitamin D deficiency on chronic diseases, such as obesity, type 2 diabetes, cardiovascular disorders etc. Recently the lower limit of vitamin D sufficiency, appeared to be safe and sufficient for skeletal health in the healthy general population, was documented as 20 ng/ml (50 nmol/l). The aim of current work is to evaluate whether the 25-OH vitamin D status is associated with the glucose control in type ...

ea0070aep551 | General Endocrinology | ECE2020

TNF-α induces hyperpolarization in agrp neurons without affecting pomc neurons of the arcuate nucleus

Chaves Fernanda , Frazao Renata , Donato Junior José

Neurons expressing the agouti-related protein (AgRP) and the pro-opiomelanocortin (POMC) are part of the central system responsible for regulating energy balance and food intake. The hypothalamus is sensitive to changes in the inflammatory state. Either high-grade inflammation (e.g., caused by sepsis) or low-grade inflammation (caused by obesity) disturbs the hypothalamic function via inflammatory cytokines. Understanding how these cytokines interact and regulate the circuits ...

ea0032p95 | Bone and Osteoporosis | ECE2013

Bone metabolism with special emphasis to osteoprotegerin and vitamin D3 concentrations in premenopausal women with thyroid dysfunction

Tuchendler Dominika , Tuchendler Renata , Skorkowska-Telichowska Katarzyna , Bolanowski Marek

Objectives: The objective was to evaluate effects of hyperthyroidism and hypothyroidism on bone metabolism in premenopausal women with special emphasis to osteoprotegerin (OPG) and vitamin D3 (vD).Materials and methods: A total of 119 women aged 18–52 years were studied (38 with recently diagnosed hyperthyroidism; 40 with newly diagnosed hypothyroidism; 41 healthy women as controls). Patients were followed up for a period of 1 year. BMD, ...

ea0032p791 | Paediatric endocrinology | ECE2013

GH treated children with IGF1 deficiency and excluded GH insensitivity despite normal GH secretion may attain similar final height as children with GH deficiency

Smyczynska Joanna , Lewinski Andrzej , Stawerska Renata , Hilczer Maciej

Introduction.: The diagnosis of GH deficiency (GHD) is based on decreased GH peak in stimulating tests (GHST). Recently, GHD has been re-defined as secondary IGF1 deficiency (IGFD). However, IGF1 may increase during GH therapy in the patients with normal GH peak in GHST, suggesting a diagnosis of non-primary IGFD (npIGFD).The aim of the study was to compare GH therapy effectiveness in children with GHD and with npIGFD (responding to GH administration des...

ea0032p800 | Paediatric endocrinology | ECE2013

Hormonal and auxological data of the patients with persistent and transient GH deficiency, diagnosed according to different criteria after completion of growth-promoting therapy

Hilczer Maciej , Smyczynska Joanna , Stawerska Renata , Lewinski Andrzej

Introduction: In majority of patients with childhood-onset GH deficiency (GHD), normalisation of GH secretion at the attainment of final height (FH) is observed. However, different criteria for GHD diagnosis may be considered.The aim of the study was to compare the auxological and hormonal data of the patients with persistent and transient GHD, diagnosed according to different criteria.Patients and methods: The analysis comprised 1...

ea0022p596 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Comparison of the efficacy of GH therapy in short children with decreased nocturnal GH secretion and either normal or subnormal results of GH stimulating tests

Hilczer Maciej , Smyczynska Joanna , Stawerska Renata , Lewinski Andrzej

Indications to GH therapy in children with short stature are still a matter of discussion.We compared first-year response to GH therapy in 80 children (62 boys, 18 girls), age 12.7±2.4 years (mean±S.D.) with different disorders of GH secretion. In all the patients nocturnal GH secretion assessed during 3 h after falling asleep was decreased (<10 ng/ml). In 40 children GH deficiency (GHD) was diagnosed on the ground of decreas...

ea0022p598 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

The occurrence of hypothyroidism during the initial phase of GH replacement therapy in children with GH deficiency: clinical implications

Smyczynska Joanna , Stawerska Renata , Lewinski Andrzej , Hilczer Maciej

Normal thyroid hormone secretion (or appropriate L-thyroxin substitution) is necessary for the optimal effect GH administration on growing rate. The decrease of free thyroxin (FT4) levels at GH therapy onset was reported in several studies.The aim of our study was to assess the incidence of hypothyroidism (HT) during the initial phase of GH administration in previously euthyroid children with GH deficiency (GHD) and to compare t...